B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Dasatinib Anhydrous

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dasatinib Anhydrous, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

neflamapimod
18 shared targets
bafetinib
18 shared targets
masitinib
18 shared targets
saracatinib
23 shared targets
golvatinib
19 shared targets
nilotinib
27 shared targets
tivozanib
17 shared targets
cep
17 shared targets
ponatinib
24 shared targets
raf
22 shared targets
Loading evidence profile...

This evidence profile for Dasatinib Anhydrous is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.